Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 

Johnson & Johnson Innovation Announces Collaborations with Two Canadian Early-Stage Drug Technology Development Centers

share with twitter share with LinkedIn share with facebook
share via e-mail
0
12/10/2013 | 02:09pm CET

Johnson & Johnson Innovation and its affiliate Janssen Inc. in Canada today announced new collaborations with two Canadian early-stage drug technology development centers, Montreal-based NEOMED and Toronto-based MaRS Innovation, to identify and advance promising bio/pharmaceutical technologies that have the potential to impact human health.

Through these collaborations, technical experts from the Johnson & Johnson Innovation Center in Boston, Massachusetts will work with NEOMED and MaRS Innovation to identify investment opportunities emerging from well-validated scientific research discoveries within their communities of academic institutions and biotechnology companies.

"We know from our history of engagement that the Canadian bio/pharmaceutical environment is one of the most vibrant in the world," said Robert Urban, Head of the Johnson & Johnson Innovation Center, Boston. "These new collaborations will allow us to potentially advance important new clinical candidates against disease."

"Quebec and Ontario are home to numerous world-class academic and biomedical research enterprises," said Paul Kershaw, Vice President of Medical Affairs, Janssen Inc. in Canada. "These new relationships with NEOMED and MaRS Innovation are an extension of our commitment to Canada's innovative research community."

NEOMED is a not-for-profit, public-private Pharma alliance dedicated to drug discovery and development. Partially funded by the Ministère des Finances et de l'Économie du Québec, NEOMED is within the NEOMED Institute, a state-of-the-art R&D facility in the Montréal Technoparc.

MaRS Innovation is the commercialization agent for Ontario's discovery pipeline from 16 leading academic institutions. MaRS Innovation is supported by the Government of Canada through the Networks of Centres of Excellence, by the Government of Ontario through the Ontario Centres of Excellence, and by its 16 member institutions.

About Johnson & Johnson Innovation

The Boston Innovation Center is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Corporation. Johnson & Johnson Innovation focuses on accelerating early innovation and enhancing opportunities for collaboration and investment across Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies focused on early-stage opportunities a one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and diagnostics and consumer companies of Johnson & Johnson. Johnson & Johnson Innovation includes local deal-making capabilities with the flexibility to adapt deal structures to match early-stage opportunities and establish novel collaborations that speed development of those innovations to solve unmet needs in patients. Follow us @jnjinnovation on Twitter. Please visit www.jnjinnovation.com for more information.

About Janssen Inc.

Janssen is dedicated to addressing and solving some of the most important unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases and vaccines, metabolic and chronic diseases and women's health. Driven by our commitment to patients, we bring innovative products, services and solutions to people throughout the world. Janssen Inc. in Canada is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. Please visit http://www.janssen.ca for more information.

Johnson & Johnson
John Lacey, 781-392-5514
jlacey1@ITS.JNJ.com
or
Feinstein Kean Healthcare
Jessica Rowlands, 202-729-4089
jessica.rowlands@fkhealth.com


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news
Date Title
12:35p ETFS PALLADIUM TRUST Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
12:35p GRESHAM HOUSE : The Royal County of Berkshire Pension Fund to Invest USD10.29 Million in Gresham House
12:35p SIMONDS : McDonald Jones Homes Acquires 5% Stake in Simonds Group
12:35p DURAN VENTURES DUP : Tartisan Resources to Acquire Don Pancho Project from Duran Ventures
12:35p LAKE RESOURCES N L : Raises USD0.92 Million in Private Placement of Ordinary Shares
12:35p INTEGRATED DEVICE TECHNOLOGY : IDT Appoints Chris Allexandre Senior VP of Global Sales and Marketing
12:34p Husqvarna Raises USD122.63 Million in Offering of Bonds Due 2022
12:34p RED PINE EXPLORATION : Acquires Additional 194 Hectares of Wawa Gold Project in Canada
12:33p BIOCRYST PHARMACEUTICALS : reports 4Q loss
12:33p GLOBAL NET LEASE : reports 4Q results
Latest news
Advertisement
Hot News 
-3.30%LONDON STOCK EXCHANGE : LSE scuppers Deutsche Boerse merger hopes by rejecting EU demand
-7.69%NOXOPHARM (ASX : NOX) talks applications for its cancer drug candidate NOX66
2.70%ESURE : UK insurer esure Group sees 2016 profit ahead of expectations
-7.79%DIRECT LINE INSURANCE : expects lower profit before tax due to discount rate change
-3.16%FTSE gains despite insurers, LSE weakness
Most Read News
04:38a BANK VTB : Russia's VTB plans to slim down in Europe, keep London as hub
05:59a LONDON STOCK EXCHANGE : LSE scuppers Deutsche Boerse merger hopes by rejecting EU demand
05:58a British motor insurance stocks slide as personal injury lump sums to rise
02/26DJOil Prices See Modest Gains; Downside Pressure Remains
12:36a HONG KONG EXCHANGES AND CLEARING : HKEX 2016 profit slides on weak trading volumes, cautious on outlook
Most recommended articles
04:58a Amazon, Netflix grab a share of Oscar glory
02/23DJVIVENDI : Full-Year Earnings Beat Estimates
06:29a Upstart analysts show banks the way in new era for research
06:24a European shares weighed down by insurers, exchange stocks
06:22a KELLER : Rotork revenue rises; to benefit from Trump moves on shale, pipelines